Getinge AB (publ) (GNGBF) Research

Getinge AB (publ) is a global provider of medical products and integrated solutions, primarily serving operating rooms, intensive care units, and sterilization departments. The company operates through three key segments: Acute Care Therapies, Life Science, and Surgical Workflows. Its diverse product lineup includes advanced sterile transfer and processing systems, washers, isolators, and sterilizers, complemented by logistical automation tools. For the life science sector, Getinge offers bioreactors, bioprocess control systems, software, analytics, and perfusion systems. Within acute care and surgical environments, its offerings encompass patient monitoring, anesthesia machines, specialized cardiac surgery devices (such as beating heart stabilizers and coronary shunts), ceiling supply units, and connected digital solutions, as well as a variety of cleaning, disinfection, packaging, and sterilization monitoring products. The company also manufactures an extensive range of specialized surgical and critical care items, including various chest drainage systems, endoscopic and endovascular products, extracorporeal life support (ECLS/ECMO) devices, and mechanical ventilators. Additionally, Getinge provides medical furniture, modular operating room systems, surgical lights and tables, OR integration and management tools, patient flow and transport solutions, and comprehensive sterile supply management. It is also a significant supplier of intra-aortic balloon pump therapies, surgical assist systems, perfusion systems, and specialized solutions for vascular and cardiothoracic surgery. Getinge distributes its products worldwide through its proprietary sales companies, as well as a broad network of agents and distributors across the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Founded in 1904, Getinge AB (publ) is headquartered in Gothenburg, Sweden.

Open Getinge AB (publ) (GNGBF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.